Novo Nordisk to discontinue Levemir insulin in U.S. market
(Reuters) – Novo Nordisk said on Wednesday it would discontinue its long-acting insulin Levemir in the United States, citing manufacturing constraints, reduced patient access and available alternatives. The Danish drugmaker said supply…
Exxon Mobil to discontinue operations at Russia’s Sakhalin-1
– Exxon Mobil Corp said on Tuesday it is starting a process to discontinue operations and developing steps to exit the Sakhalin-1 venture in Russia. The company said it would not invest…
Breaking News
